In the future, Acorai will be the standard procedure to measure Pulmonary Artery Pressure and is equally accurate to the right heart catheterization method.
The patient does not have to suffer an invasive procedure and measurements can be taken more frequently. Measuring with Acorai only takes a few minutes and does not require a specialist team, room and other equipment. The device is simply held onto the patient’s chest while data is collected by the five different sensors, analyzed with machine learning and the result is displayed to the medical practitioner.
Acorai can help decrease mortality rates for heart failure patients, reduce costs significantly and offer a better experience for the affected patient.